Skip to content

Biomarkers of cartilage and bone damage after joint bleeds in haemophiliacs

Biomarkers of cartilage and bone damage after joint bleeds in haemophiliacs - Biomarkers after joint bleeds in haemophiliacs

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39118
Enrollment
10
Registered
2008-03-18
Start date
2009-01-16
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clotting factor VIII/IX deficiency

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Haemophilia, joint bleed

Exclusion criteria

Exclusion criteria: HIV positivity, overweight, antibodies against clotting factor

Design outcomes

Primary

MeasureTime frame
Biomarkers of cartilage and bone turnover.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)